Webinar: Advancements in Antibody Technologies and Protein Data in Cancer Research

Join us for an insightful webinar featuring two distinguished experts exploring the latest advancements in precision oncology. From cutting-edge antibody-based biomarker discovery to breakthrough digital PCR applications, this session will highlight transformative tools driving innovation in cancer diagnostics and treatment.

Card image cap

Card image cap

Card image cap

Online

Advancements in antibody technologies and protein data are driving new possibilities in cancer research, enabling the identification of novel biomarkers and enhancing therapeutic strategies.

In this webinar, Dr. Eugenia Kuteeva will explore how Atlas Antibodies, developed from the Human Protein Atlas, can support biomarker discovery, improve patient stratification and refine therapeutic targeting in precision oncology. She will also introduce MolBoolean, an innovative in situ proximity tool, unlocking deeper insights into cancer biology. 

We’re also excited to welcome Dr. Trevor Pitcher from Biodesix, who will discuss the future of cancer diagnostics and how ddPCR enables the rapid identification of actionable mutations to drive personalized therapeutic strategies.

  • Date: March 27th, 2025
  • Time: 5:00 PM (GMT+01:00)

 

Register here       Learn more about Atlas Antibodies       Learn more about MolBoolean